サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1756481

無細胞胎児DNA検査市場：キット別、サンプルタイプ別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測

Cell Free Fetal DNA Testing Market, By Kits, By Sample Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 400 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
無細胞胎児DNA検査市場：キット別、サンプルタイプ別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2025年05月23日
発行: AnalystView Market Insights
ページ情報: 英文 400 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

無細胞胎児DNA検査市場規模は2024年に16億5,412万米ドルとなり、2024～2032年にかけてCAGR 6.5％で拡大

無細胞胎児DNA検査市場-市場力学

非侵襲的出生前検査への需要の高まり

非侵襲的出生前検査（NIPT）への嗜好の高まりは、無細胞胎児DNA検査市場の主要な促進要因です。胎児DNA検査は、羊水穿刺のような侵襲的な処置に代わるより安全な選択肢を提供し、流産のリスクを低減するため、妊婦やヘルスケアプロバイダに支持されています。さらに、遺伝性疾患の早期発見により、より良い妊娠管理と情報に基づいた意思決定が可能になります。技術の進歩により、検査の精度が向上し、コストが削減されたため、cffDNA検査はより身近なものとなっています。出生前の健康や遺伝的疾患に対する意識の高まりが需要をさらに押し上げ、世界の市場成長を加速させています。

無細胞胎児DNA検査市場-主要な洞察

当社のリサーチアナリストによると、世界の無細胞胎児DNA検査市場は、2024～2032年の間に約6.5％のCAGRで発展する見込みです。

2024年のキット別セグメントでは、PCR & qPCRベースのcffDNA検査キットカテゴリが市場を独占しています。

エンドユーザー別では、2024年に最も収益を上げたのは診断ラボ部門でした。

地域別では、2024年に北米が最も高い収益を上げた地域でした。

無細胞胎児DNA検査市場-セグメンテーション分析

世界の無細胞胎児DNA検査市場は4つのカテゴリーに分類されます：キット、エンドユーザー、サンプルタイプ、地域。

キット別では、無細胞胎児DNA検査市場は、無細胞DNA抽出・精製キット、PCR・qPCRベースのcffDNA検査キット、NGSベースのcffDNA検査キットに区分されます。抽出・精製キットは、母体血から高品質の胎児DNAを分離し、正確な検査の基礎を形成するために不可欠です。PCRとqPCRベースのキットは、増幅技術を用いて特定の遺伝子マーカーや変異を迅速かつコスト効率よく検出します。一方、NGSベースのcffDNA検査キットは、より高い感度と精度で複数の染色体異常の検出を含む包括的な遺伝子分析を提供するために、先進的次世代シーケンス技術を採用しています。これらのうち、PCR＆qPCRベースのcffDNA検査キットは、正確性、手頃な価格、迅速な納期のバランスのため、現在市場を独占しており、世界的に臨床現場で広く好まれています。

エンドユーザー別では、無細胞胎児DNA検査市場は病院、産科クリニック、診断ラボ、学術・研究機関に分類されます。病院は、包括的な出産前ケアを提供し、多くの場合、ルーチンのスクリーニングの一部としてcffDNA検査を統合し、幅広い患者層に対応しています。マタニティクリニックは、専門的な母体と胎児の健康サービスに重点を置き、個による検査オプションを提供しています。診断検査機関は、医療提供者に高性能で専門的な検査サービスを提供し、正確でタイムリーな結果を保証することで、重要な役割を果たしています。学術研究機関は、検査技術の進歩や臨床研究の実施を通じて貢献しています。中でも診断検査機関は、その専門的なインフラ、専門知識、大量の検査を効率的に処理する能力により市場を独占しており、世界中のcffDNA検査サービスの中心的な拠点となっています。

無細胞胎児DNA検査市場-地理的洞察

地域的には、無細胞胎児DNA検査市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米は無細胞胎児DNA検査市場において支配的な地域であり、主に米国とカナダが牽引しています。この地域は、先進的ヘルスケアインフラ、最先端技術の高い採用率、出生前の健康に対する強い意識から利益を得ています。有利な償還施策と主要市場参入企業の存在が市場成長をさらに後押ししています。さらに、遺伝子研究への投資の増加と非侵襲的な出生前検査への需要の高まりが北米の主導的地位に寄与しており、cffDNA検査の世界最大市場の一つとなっています。

アジア太平洋は、中国、インド、日本などの国々に牽引され、無細胞胎児DNA検査市場で急成長を示しているもう一つの主要地域です。ヘルスケア支出の増加、出生前診断に対する意識の高まり、医療インフラの拡大が市場拡大の原動力となっています。中産階級の人口増加と先進的検査技術へのアクセスの向上が需要を促進しています。さらに、母子の健康増進を目的とした政府の取り組みや民間セクタの参入増加が、アジア太平洋の市場成長を加速させており、アジア太平洋をcffDNA検査の主要新興市場として位置付けています。

無細胞胎児DNA検査市場-競合情勢

無細胞胎児DNA検査市場の競合情勢は、革新的な新興企業とともに、既存のバイオテクノロジー企業や分子診断企業によって形成されています。QIAGEN、Thermo Fisher Scientific、Takara Bio、Promegaのような大手企業は、精度、感度、使いやすさに焦点を当てた先進的な検査キットと技術で優位を占めています。これらの企業は、検査性能を高め、規制基準に適合させるため、研究開発に多額の投資を行っています。新興企業は、診断能力を拡大するために、新規のシークエンシングやバイオインフォマティクスソリューションを導入しています。このような競合環境が継続的な技術革新を促進し、市場成長と非侵襲的出生前検査の世界の普及を促進しています。

目次

第1章 無細胞胎児DNA検査市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 無細胞胎児DNA検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 無細胞胎児DNA検査産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 無細胞胎児DNA検査市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 無細胞胎児DNA検査市場情勢

  • 無細胞胎児DNA検査市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • ベテラン選手の分析
    • 新興企業の分析

第7章 無細胞胎児DNA検査市場-キット別

  • 概要
    • キット別セグメントシェア分析
    • 無細胞DNA抽出・精製キット
    • PCRとqPCRベースのcffDNA検査キット
    • NGSベースのcffDNA検査キット

第8章 無細胞胎児DNA検査市場-サンプルタイプ別

  • 概要
    • サンプルタイプ別セグメントシェア分析
    • 母体血漿/血清
    • 尿cfDNA

第9章 無細胞胎児DNA検査市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 産科クリニック
    • 診断ラボ
    • 学術・研究機関

第10章 無細胞胎児DNA検査市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-無細胞胎児DNA検査産業

  • 競合ダッシュボード
  • 企業プロファイル
    • QIAGEN
    • Thermo Fisher Scientific
    • Takara Bio
    • Nonacus
    • Promega
    • VWR
    • OmegabIoTek
    • Nvigen
    • BioChain
    • Norgen BIoTek
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV5276

REPORT HIGHLIGHT

Cell Free Fetal DNA Testing Market size was valued at USD 1,654.12 Million in 2024, expanding at a CAGR of 6.5% from 2024 to 2032.

The Cell Free Fetal DNA (cffDNA) Testing Market involves the development, production, and sale of non-invasive prenatal testing (NIPT) technologies that analyze fetal DNA fragments circulating in a pregnant woman's blood. This testing helps detect genetic abnormalities, such as Down syndrome, Edwards syndrome, and Patau syndrome, early in pregnancy without risk to the fetus. The market includes diagnostic laboratories, healthcare providers, and biotechnology companies offering cffDNA-based screening kits and services. Growing awareness of prenatal health, increasing demand for safe and accurate fetal genetic testing, and advancements in genomic technologies are driving the market's expansion globally.

Cell Free Fetal DNA Testing Market- Market Dynamics

Rising Demand for Non-Invasive Prenatal Testing

The increasing preference for non-invasive prenatal testing (NIPT) is a key driver of the Cell Free Fetal DNA Testing Market. Expectant mothers and healthcare providers favor cffDNA testing because it offers a safer alternative to invasive procedures like amniocentesis, reducing the risk of miscarriage. Additionally, early detection of genetic disorders enables better pregnancy management and informed decision-making. Advances in technology have improved test accuracy and reduced costs, making cffDNA testing more accessible. Growing awareness about prenatal health and genetic conditions further boosts demand, accelerating market growth worldwide.

Cell Free Fetal DNA Testing Market- Key Insights

According to our research analyst, the global Cell Free Fetal DNA Testing Market is expected to develop at a CAGR of approximately 6.5% between 2024-2032.

Segmented by Kits in 2024, the PCR & qPCR-Based cffDNA Testing Kits category dominated the market.

Based on End User, the Diagnostic Laboratories segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Cell Free Fetal DNA Testing Market- Segmentation Analysis:

The global Cell Free Fetal DNA Testing Market is divided into Four categories: Kits, End User, Sample Type, and Region.

By kits, the Cell Free Fetal DNA Testing Market is segmented into Cell-Free DNA Extraction & Purification Kits, PCR & qPCR-Based cffDNA Testing Kits, and NGS-Based cffDNA Testing Kits. Extraction and purification kits are essential for isolating high-quality fetal DNA from maternal blood, forming the foundation for accurate testing. PCR and qPCR-based kits use amplification techniques to detect specific genetic markers and mutations quickly and cost-effectively. Meanwhile, NGS-based cffDNA testing kits employ advanced next-generation sequencing technology to provide comprehensive genetic analysis, including the detection of multiple chromosomal abnormalities with higher sensitivity and precision. Among these, PCR & qPCR-based cffDNA Testing Kits currently dominate the market due to their balance of accuracy, affordability, and faster turnaround time, making them widely preferred in clinical settings globally.

By end user, the Cell Free Fetal DNA Testing Market is categorized into Hospitals, Maternity Clinics, Diagnostic Laboratories, and Academic & Research Institutions. Hospitals offer comprehensive prenatal care and often integrate cffDNA testing as part of routine screenings, catering to a broad patient base. Maternity clinics focus on specialized maternal and fetal health services, providing personalized testing options. Diagnostic laboratories play a critical role by offering high-throughput, specialized testing services to healthcare providers, ensuring accuracy and timely results. Academic and research institutions contribute by advancing testing technologies and conducting clinical studies. Among these, diagnostic laboratories dominate the market due to their specialized infrastructure, expertise, and ability to handle large volumes of tests efficiently, making them central hubs for cffDNA testing services worldwide.

Cell Free Fetal DNA Testing Market- Geographical Insights

Geographically, the Cell Free Fetal DNA Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Cell Free Fetal DNA Testing Market, driven primarily by the United States and Canada. The region benefits from advanced healthcare infrastructure, high adoption of cutting-edge technologies, and strong awareness about prenatal health. Favorable reimbursement policies and the presence of key market players further boost market growth. Additionally, increasing investments in genetic research and growing demand for non-invasive prenatal testing contribute to North America's leading position, making it one of the largest markets globally for cffDNA testing.

Asia Pacific is another key region showing a rapid growth in the Cell Free Fetal DNA Testing Market, led by countries like China, India, and Japan. Rising healthcare expenditure, increasing awareness of prenatal diagnostics, and expanding healthcare infrastructure are driving market expansion. The growing middle-class population and improving access to advanced testing technologies are fueling demand. Additionally, government initiatives aimed at improving maternal and child health and increasing private sector participation are accelerating market growth in this region, positioning Asia Pacific as a major emerging market for cffDNA testing.

Cell Free Fetal DNA Testing Market- Competitive Landscape:

The competitive landscape of the Cell Free Fetal DNA Testing Market is shaped by established biotechnology and molecular diagnostics companies alongside innovative startups. Leading players like QIAGEN, Thermo Fisher Scientific, Takara Bio, and Promega dominate with advanced testing kits and technologies focused on accuracy, sensitivity, and ease of use. These companies invest significantly in R&D to enhance test performance and comply with regulatory standards. Emerging firms are introducing novel sequencing and bioinformatics solutions to expand diagnostic capabilities. This competitive environment fosters continuous innovation, driving market growth and broader adoption of non-invasive prenatal testing worldwide.

Recent Developments:

In April 2024, QIAGEN launched a new, streamlined cffDNA extraction kit aimed at reducing sample processing time while maintaining high purity and yield.

In January 2025, Thermo Fisher Scientific expanded its prenatal genetic testing portfolio by acquiring a specialist NGS-based cffDNA testing startup to enhance its market reach and technological offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL FREE FETAL DNA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • QIAGEN
  • Thermo Fisher Scientific
  • Takara Bio
  • Nonacus
  • Promega
  • VWR
  • Omegabiotek
  • Nvigen
  • BioChain
  • Norgen Biotek
  • Others

GLOBAL CELL FREE FETAL DNA TESTING MARKET, BY KITS - MARKET ANALYSIS, 2019 - 2032

  • Cell-Free DNA Extraction & Purification Kits
  • Pcr & Qpcr-Based Cffdna Testing Kits
  • Ngs-Based Cffdna Testing Kits

GLOBAL CELL FREE FETAL DNA TESTING MARKET, BY SAMPLE TYPE - MARKET ANALYSIS, 2019 - 2032

  • Maternal Plasma/Serum
  • Urine cfDNA

GLOBAL CELL FREE FETAL DNA TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospital
  • Maternity Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutions

GLOBAL CELL FREE FETAL DNA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Free Fetal DNA Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Free Fetal DNA Testing Market Snippet by Kits
    • 2.1.2. Cell Free Fetal DNA Testing Market Snippet by Sample Type
    • 2.1.3. Cell Free Fetal DNA Testing Market Snippet by End User
    • 2.1.4. Cell Free Fetal DNA Testing Market Snippet by Country
    • 2.1.5. Cell Free Fetal DNA Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Free Fetal DNA Testing Key Market Trends

  • 3.1. Cell Free Fetal DNA Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Free Fetal DNA Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Free Fetal DNA Testing Market Opportunities
  • 3.4. Cell Free Fetal DNA Testing Market Future Trends

4. Cell Free Fetal DNA Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Free Fetal DNA Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell Free Fetal DNA Testing Market Landscape

  • 6.1. Cell Free Fetal DNA Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Free Fetal DNA Testing Market - By Kits

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Kits, 2023 & 2032 (%)
    • 7.1.2. Cell-Free DNA Extraction & Purification Kits
    • 7.1.3. PCR & qPCR-Based cffDNA Testing Kits
    • 7.1.4. NGS-Based cffDNA Testing Kits

8. Cell Free Fetal DNA Testing Market - By Sample Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
    • 8.1.2. Maternal Plasma/Serum
    • 8.1.3. Urine cfDNA

9. Cell Free Fetal DNA Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Maternity Clinics
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Academic & Research Institutions

10. Cell Free Fetal DNA Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell Free Fetal DNA Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell Free Fetal DNA Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell Free Fetal DNA Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cell Free Fetal DNA Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cell Free Fetal DNA Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cell Free Fetal DNA Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. QIAGEN
    • 11.2.2. Thermo Fisher Scientific
    • 11.2.3. Takara Bio
    • 11.2.4. Nonacus
    • 11.2.5. Promega
    • 11.2.6. VWR
    • 11.2.7. Omegabiotek
    • 11.2.8. Nvigen
    • 11.2.9. BioChain
    • 11.2.10. Norgen Biotek
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us